Stocks
Atara Biotherapeutics (ATRA) Debt/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 1.04 | 0.77 | -0.02 | -0.02 | 1.15 | -0.13 | |||
| Changes by years, y/y, % | -36% | -26% | -103% | -24% | -6 610% | -6.6% | |||
Atara Biotherapeutics. Debt/EBITDA
Atara Biotherapeutics. Debt/EBITDA, changes, %
Atara Biotherapeutics (ATRA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Debt/EBITDA | -7.17 | -0.33 | 1.47 | 1.15 | -0.32 | -0.13 | ||
| Changes by years, y/y, % | +15 908% | +219% | +8 800% | -6 610% | -96% | |||
| Changes by quarters, q/q, % | +40 594% | -95% | -553% | -22% | -128% | |||
